QUANTITATIVE VASOCONSTRICTOR ASSAY FOR TOPICAL CORTICOSTEROIDS - THE PUZZLING CASE OF FLUOCINOLONE ACETONIDE

被引:17
作者
GUIN, JD
WALLIS, MS
WALLS, R
LEHMAN, PA
FRANZ, TJ
机构
[1] UNIV ARKANSAS MED SCI HOSP,DEPT DERMATOL,SLOT 576,4301 W MARKHAM ST,LITTLE ROCK,AR 72205
[2] UNIV ARKANSAS MED SCI HOSP,BIOMETR SECT,LITTLE ROCK,AR 72205
关键词
D O I
10.1016/0190-9622(93)70167-R
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: The validity of the vasoconstrictor test has been questioned because of the apparent nonequivalence of some generic corticosteroid products. Objective: Our purpose was to determine the vasoconstrictor activity of a generic 0.025% fluocinolone acetonide ointment by two different methods, dilution by volume and dilution by area of application. Methods: Vasoconstrictor activity on a visual 4-point scale was measured in 20 volunteers. Topical fluocinolone acetonide ointment (0.025%) was tested by comparing dilution by volume (1:1, 1:3, and 1:7) in petrolatum and dilution by area of application. Fluocinolone release from the diluted ointments was also measured with an in vitro method. Results: Dilution by area gave the expected results, a decreasing average vasoconstrictor score; but dilution by volume did not. Both the 1:1 and 1:3 dilutions inexplicably showed greater activity than the full-strength product; this finding was similarly reflected in the in vitro studies that showed a greater rate of drug release from the 1:1 and 1:3 dilutions. Conclusion: Dilution by area provides a useful quantitative assay for comparative vasoconstrictor activity.
引用
收藏
页码:197 / 202
页数:6
相关论文
共 17 条
[1]   PROPRIETARY HYDROCORTISONE CREAMS - VASOCONSTRICTOR ACTIVITIES AND BIO-AVAILABILITIES OF 6 PREPARATIONS [J].
BARRY, BW ;
WOODFORD, R .
BRITISH JOURNAL OF DERMATOLOGY, 1976, 95 (04) :423-425
[2]   COMPARATIVE BIO-AVAILABILITY AND ACTIVITY OF PROPRIETARY TOPICAL CORTICOSTEROID PREPARATIONS - VASOCONSTRICTOR ASSAYS ON 31 OINTMENTS [J].
BARRY, BW ;
WOODFORD, R .
BRITISH JOURNAL OF DERMATOLOGY, 1975, 93 (05) :563-571
[3]  
BARRY BW, 1989, PERCUTANEOUS ABSORPT, P531
[4]  
CHRISTIE BA, 1970, BR J DERMATOL S6, V82, P93
[5]   BIOEQUIVALENCE (BIOAVAILABILITY) OF GENERIC TOPICAL CORTICOSTEROIDS [J].
JACKSON, DB ;
THOMPSON, C ;
MCCORMACK, JR ;
GUIN, JD .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1989, 20 (05) :791-796
[6]  
MATTISON N, 1986, Pharmaceutical Medicine (London), V1, P177
[7]   METHOD FOR COMPARING PERCUTANEOUS ABSORPTION OF STEROIDS [J].
MCKENZIE, AW ;
STOUGHTON, RB .
ARCHIVES OF DERMATOLOGY, 1962, 86 (05) :608-&
[8]  
MCKENZIE AW, 1962, ARCH DERMATOL, V86, P611, DOI 10.1001/archderm.1962.01590110047006
[10]  
OSTRENGA J, 1971, J INVEST DERMATOL, V56, P372